The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer.
Saved in:
| Title: | The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer. |
|---|---|
| Authors: | Neoptolemos JP; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany. Electronic address: john.neoptolemos@med.uni-heidelberg.de., Springfeld C; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Öhlund D; Department of Diagnostics and Intervention (Oncology), and Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden., Büchler MW; Champalimaud Foundation, Avenida Brasilia, Lisbon, Portugal., Michalski CW; Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2026 Jan; Vol. 27 (1), pp. e3. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
